The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Bone health in cancer patients: ESMO Clinical Practice Guidelines
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Radioisotopes for metastatic bone pain
Figuls, M. R. I., Martínez‐Zapata, M. J., Alonso‐Coello, P., Català, E., Fernández, J. L. G., & Ferrandiz, M. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003347 · Cited by 104
RetractedRadioisotopes for metastatic bone pain
Figuls, M. R. I., Martínez‐Zapata, M. J., Scott-Brown, M., & Alonso‐Coello, P. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003347.pub2 · Cited by 50
RetractedAlpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
Parker, C., Nilsson, S., Heinrich, D., Helle, S. I., O'Sullivan, J. M., Fosså, S. D., Chodacki, A., Wiechno, P., Logue, J., Seke, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213755 · Cited by 3,408
Self-citationOnce-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis
Black, D. M., Delmas, P. D., Eastell, R., Reid, I. R., Boonen, S., Cauley, J. A., Cosman, F., Lakatos, P., Leung, P. C., Man, Z., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067312 · Cited by 2,986
Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity
Coleman, R. E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0931 · Cited by 2,488
Self-citationFRAX™ and the assessment of fracture probability in men and women from the UK
Kanis, J. A., Johnell, O., Oden, A., Johansson, H., & McCloskey, E. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0543-5 · Cited by 2,467
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
Seeman, E., & Delmas, P. D. (2006) · New England Journal of Medicine · doi:10.1056/nejmra053077 · Cited by 2,080
Fizazi, K., Carducci, M., Smith, M., Damião, R., Brown, J., Karsh, L., Milecki, P., Shore, N., Rader, M., Wang, H., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62344-6 · Cited by 1,971
Khosla, S., Burr, D., Cauley, J., Dempster, D. W., Ebeling, P. R., Felsenberg, D., Gagel, R. F., Gilsanz, V., Guise, T., Koka, S., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0707onj · Cited by 1,650 · cited 1×
“The definition, diagnosis and follow-up of ONJ have been reviewed by an American Society for Bone and Mineral Research task force and various experts [83, 84].”
Stopeck, A. T., Lipton, A., Body, J.-J., Steger, G. G., Tonkin, K., de Boer, R. H., Lichinitser, M., Fujiwara, Y., Yardley, D. A., Viniegra, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.7101 · Cited by 1,597
Self-citationPerspective how many women have osteoporosis?
Dr. Melton, L. J., Chrischilles, E. A., Cooper, C., Lane, A. W., & Riggs, B. L. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070902 · Cited by 1,400
Risk of Fracture after Androgen Deprivation for Prostate Cancer
Shahinian, V. B., Kuo, Y.-F., Freeman, J. L., & Goodwin, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041943 · Cited by 1,375
Cancer to bone: a fatal attraction
Weilbaecher, K. N., Guise, T. A., & McCauley, L. K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3055 · Cited by 1,285
Henry, D. H., Costa, L., Goldwasser, F., Hirsh, V., Hungria, V., Prausova, J., Scagliotti, G. V., Sleeboom, H., Spencer, A., Vadhan-Raj, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.3304 · Cited by 1,263
Tang, B. M., Eslick, G. D., Nowson, C., Smith, C., & Bensoussan, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61342-7 · Cited by 1,248
Siris, E. S., Miller, P. D., Barrett-Connor, E., Faulkner, K. G., Wehren, L. E., Abbott, T. A., Berger, M. L., Santora, A. C., & Sherwood, L. M. (2001) · JAMA · doi:10.1001/jama.286.22.2815 · Cited by 1,211
Saad, F., Gleason, D. M., Murray, R., Tchekmedyian, S., Venner, P., Lacombe, L., Chin, J. L., Vinholes, J. J., Goas, J. A., & Zheng, M. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh141 · Cited by 1,201
Denosumab in men receiving androgen-deprivation therapy for prostate cancer
Smith, M. R., Egerdie, B., Toriz, N. H., Feldman, R., Tammela, T. L. J., Saad, F., Heracek, J., Szwedowski, M., Ke, C., Kupic, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809003 · Cited by 1,140
Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma
Berenson, J. R., Lichtenstein, A., Porter, L., Dimopoulos, M. A., Bordoni, R., George, S., Lipton, A., Keller, A., Ballester, O., Kovacs, M. J., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602223340802 · Cited by 1,081
Rosen, L. S., Gordon, D., Kaminski, M., Howell, A., Belch, A. R., Mackey, J. R., Apffelstaedt, J., Hussein, M., Coleman, R. E., Reitsma, D. J., et al. (2001) · PubMed · Cited by 896
Self-citationRosen, L. S., Gordon, D., Kaminski, M., Howell, A., Belch, A., Mackey, J., Apffelstaedt, J., Hussein, M. A., Coleman, R. E., Reitsma, D. J., et al. (2003) · Cancer · doi:10.1002/cncr.11701 · Cited by 873
Self-citationSmith, M. R., Saad, F., Coleman, R., Shore, N., Fizazi, K., Tombal, B., Miller, K., Sieber, P., Karsh, L., Damião, R., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61226-9 · Cited by 797
Self-citationRosen, L. S., Gordon, D., Tchekmedyian, N. S., Yanagihara, R., Hirsh, V., Krzakowski, M., Pawlicki, M., de Souza, P., Zheng, M., Urbanowitz, G., et al. (2004) · Cancer · doi:10.1002/cncr.20308 · Cited by 705
Pamidronate to Prevent Bone Loss during Androgen-Deprivation Therapy for Prostate Cancer
Smith, M. R., McGovern, F. J., Zietman, A. L., Fallon, M. A., Hayden, D. L., Schoenfeld, D. A., Kantoff, P. W., & Finkelstein, J. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010845 · Cited by 696
Preparing the “Soil”: The Premetastatic Niche
Kaplan, R. N., Rafii, S., & Lyden, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2407 · Cited by 665
Endogenous Hormones and the Risk of Hip and Vertebral Fractures among Older Women
Cummings, S. R., Browner, W. S., Bauer, D., Stone, K., Ensrud, K., Jamal, S., & Ettinger, B. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809103391104 · Cited by 660
Dykewicz, C. A. (2001) · Clinical Infectious Diseases · doi:10.1086/321805 · Cited by 636
Hortobagyi, G. N., Theriault, R. L., Lipton, A., Porter, L., Blayney, D., Sinoff, C., Wheeler, H., Simeone, J. F., Seaman, J. J., Knight, R. D., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.6.2038 · Cited by 631
Theriault, R. L., Lipton, A., Hortobagyi, G. N., Leff, R., Glück, S., Stewart, J. F., Costello, S., Kennedy, I., Simeone, J., Seaman, J. J., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.846 · Cited by 604
Lipton, A., Fizazi, K., Stopeck, A. T., Henry, D. H., Brown, J. E., Yardley, D. A., Richardson, G. E., Siena, S., Maroto, P., Clemens, M., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.08.002 · Cited by 588
Morgan, G. J., Davies, F. E., Gregory, W. M., Cocks, K., Bell, S. E., Szubert, A. J., Navarro-Coy, N., Drayson, M. T., Owen, R. G., Feyler, S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)62051-x · Cited by 575
Brown, J. E., Cook, R. J., Major, P., Lipton, A., Saad, F., Smith, M., Lee, K.-A., Zheng, M., Hei, Y.-J., & Coleman, R. E. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji002 · Cited by 559
Self-citationPaterson, A. H., Powles, T. J., Kanis, J. A., McCloskey, E., Hanson, J., & Ashley, S. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.1.59 · Cited by 557
Fizazi, K., Lipton, A., Mariette, X., Body, J.-J., Rahim, Y., Gralow, J. R., Gao, G., Wu, L., Sohn, W., & Jun, S. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.2146 · Cited by 533
Self-citationBody, J.-J., Facon, T., Coleman, R. E., Lipton, A., Geurs, F., Fan, M., Holloway, D., Peterson, M. C., & Bekker, P. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1933 · Cited by 490
Self-citationEllis, G. K., Bone, H. G., Chlebowski, R., Paul, D., Spadafora, S., Smith, J., Fan, M., & Jun, S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.3832 · Cited by 483
Gnant, M., Mlineritsch, B., Stoeger, H., Luschin-Ebengreuth, G., Heck, D., Menzel, C., Jakesz, R., Seifert, M., Hubalek, M., Pristauz, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70122-x · Cited by 472
Aapro, M., Abrahamsson, P. A., Body, J. J., Coleman, R. E., Colomer, R., Costa, L., Crinò, L., Dirix, L., Gnant, M., Gralow, J., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdm442 · Cited by 457
Self-citationBreast-Cancer Adjuvant Therapy with Zoledronic Acid
Coleman, R. E., Marshall, H., Cameron, D., Dodwell, D., Burkinshaw, R., Keane, M., Gil, M., Houston, S. J., Grieve, R. J., Barrett-Lee, P. J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105195 · Cited by 424
Self-citationBody, J.-J., Diel, I. J., Lichinitser, M. R., Kreuser, E. D., Dornoff, W., Gorbunova, V. A., Budde, M., & Bergström, B. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg367 · Cited by 413
Self-citationBreast-cancer Adjuvant Therapy With Zoledronic Acid
Coleman, R. E., Marshall, H. C., Cameron, D., et al. (2011) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · Cited by 413
Self-citationKyle, R. A., Yee, G. C., Somerfield, M. R., Flynn, P. J., Halabi, S., Jagannath, S., Orlowski, R. Z., Roodman, D. G., Twilde, P., & Anderson, K. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.1269 · Cited by 409
Smith, M. R., Lee, W. C., Brandman, J., Wang, Q., Botteman, M., & Pashos, C. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.6908 · Cited by 366
Terpos, E., Morgan, G., Dimopoulos, M. A., Drake, M. T., Lentzsch, S., Raje, N., Sezer, O., García-Sanz, R., Shimizu, K., Turesson, I., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.7901 · Cited by 352
Van Poznak, C. H., Temin, S., Yee, G. C., Janjan, N. A., Barlow, W. E., Biermann, J. S., Bosserman, L. D., Geoghegan, C., Hillner, B. E., Theriault, R. L., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.5209 · Cited by 342
Coleman, R., de Boer, R., Eidtmann, H., Llombart, A., Davidson, N., Neven, P., von Minckwitz, G., Sleeboom, H. P., Forbes, J., Barrios, C., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds277 · Cited by 339
Self-citationBody, J. J., Diel, I. J., Lichinitzer, M., Lazarev, A., Pecherstorfer, M., Bell, R., Tripathy, D., & Bergstrom, B. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601663 · Cited by 336
Self-citationScagliotti, G. V., Hirsh, V., Siena, S., Henry, D. H., Woll, P. J., Manegold, C., Solal-Celigny, P., Rodriguez, G., Krzakowski, M., Mehta, N. D., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31826aec2b · Cited by 335
Fracture Risk With Multiple Myeloma: A Population-Based Study
Melton, L. J., Kyle, R. A., Achenbach, S. J., Oberg, A. L., & Rajkumar, S. V. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041131 · Cited by 332
Michaelson, M. D., Kaufman, D. S., Lee, H., McGovern, F. J., Kantoff, P. W., Fallon, M. A., Finkelstein, J. S., & Smith, M. R. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.3361 · Cited by 330
A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma
McCloskey, MacLennan, Drayson, Chapman, Dunn, Kanis, & Adults, F. T. M. W. P. O. L. I. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00567.x · Cited by 314
Compston, J., Bowring, C., Cooper, A., Cooper, C., Davies, C., Francis, R., Kanis, J. A., Marsh, D., McCloskey, E. V., Reid, D. M., et al. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.05.013 · Cited by 304
Bisphosphonates for the relief of pain secondary to bone metastases
Wong, R. K., & Wiffen, P. J. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002068 · Cited by 285
Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST
Costelloe, C. M., Chuang, H. H., Madewell, J. E., & Ueno, N. T. (2010) · Journal of Cancer · doi:10.7150/jca.1.80 · Cited by 270
LeBlanc, E. S., Nielson, C. M., Marshall, L. M., Lapidus, J. A., Barrett-Connor, E., Ensrud, K. E., Hoffman, A. R., Laughlin, G., Ohlsson, C., Orwoll, E. S., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0206 · Cited by 240
Terpos, E., Sezer, O., Croucher, P. I., García-Sanz, R., Boccadoro, M., San Miguel, J., Ashcroft, J., Bladé, J., Cavo, M., Delforge, M., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn796 · Cited by 230
Mayo Clinic Consensus Statement for the Use of Bisphosphonates in Multiple Myeloma
Lacy, M. Q., Dispenzieri, A., Gertz, M. A., Greipp, P. R., Gollbach, K. L., Hayman, S. R., Kumar, S., Lust, J. A., Rajkumar, S. V., Russell, S. J., et al. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.8.1047 · Cited by 228
Reid, D. M., Doughty, J., Eastell, R., Heys, S. D., Howell, A., McCloskey, E. V., Powles, T., Selby, P., & Coleman, R. E. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.03.007 · Cited by 228
Self-citationPrevention of Aromatase Inhibitor–Induced Bone Loss Using Risedronate: The SABRE Trial
Van Poznak, C., Hannon, R. A., Mackey, J. R., Campone, M., Apffelstaedt, J. P., Clack, G., Barlow, D., Makris, A., & Eastell, R. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.5902 · Cited by 224
Amadori, D., Aglietta, M., Alessi, B., Gianni, L., Ibrahim, T., Farina, G., Gaion, F., Bertoldo, F., Santini, D., Rondena, R., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70174-8 · Cited by 203
Bisphosphonates: Molecular Mechanisms of Action and Effects on Bone Cells, Monocytes and Macrophages
J. Roelofs, A., Thompson, K., H. Ebetino, F., J. Rogers, M., & P. Coxon, F. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210793563635 · Cited by 202
Paterson, A. H., Anderson, S. J., Lembersky, B. C., Fehrenbacher, L., Falkson, C. I., King, K. M., Weir, L. M., Brufsky, A. M., Dakhil, S., Lad, T., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70226-7 · Cited by 194
Hadji, P., Aapro, M. S., Body, J. J., Bundred, N. J., Brufsky, A., Coleman, R. E., Gnant, M., Guise, T., & Lipton, A. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr017 · Cited by 191
Self-citationLester, J. E., Dodwell, D., Purohit, O. P., Gutcher, S. A., Ellis, S. P., Thorpe, R., Horsman, J. M., Brown, J. E., Hannon, R. A., & Coleman, R. E. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5101 · Cited by 189
Self-citationYong, M., Jensen, A. Ø., Jacobsen, J. B., Nørgaard, M., Fryzek, J. P., & Sørensen, H. T. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1475-5 · Cited by 185
Effects of Bone-Targeted Agents on Cancer Progression and Mortality
Coleman, R., Gnant, M., Morgan, G., & Clezardin, P. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs263 · Cited by 184
Self-citationHenry, D., Vadhan-Raj, S., Hirsh, V., von Moos, R., Hungria, V., Costa, L., Woll, P. J., Scagliotti, G., Smith, G., Feng, A., et al. (2014) · Supportive Care in Cancer · doi:10.1007/s00520-013-2022-1 · Cited by 183 · cited 1×
“017) [67].”
The Role of External Beam Radiotherapy in the Management of Bone Metastases
Agarawal, J. P., Swangsilpa, T., van der Linden, Y., Rades, D., Jeremic, B., & Hoskin, P. J. (2006) · Clinical Oncology · doi:10.1016/j.clon.2006.09.007 · Cited by 183
Coleman, R. E., & McCloskey, E. V. (2011) · Bone · doi:10.1016/j.bone.2011.02.003 · Cited by 181
Self-citationHadji, P. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.07.013 · Cited by 165
Self-citationMorgan, G. J., Child, J. A., Gregory, W. M., Szubert, A. J., Cocks, K., Bell, S. E., Navarro-Coy, N., Drayson, M. T., Owen, R. G., Feyler, S., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70157-7 · Cited by 165
Cleeland, C. S., Body, J., Stopeck, A., von Moos, R., Fallowfield, L., Mathias, S. D., Patrick, D. L., Clemons, M., Tonkin, K., Masuda, N., et al. (2013) · Cancer · doi:10.1002/cncr.27789 · Cited by 159
Self-citationBeuselinck, B., Oudard, S. M., Rixe, O., Wolter, P., Blesius, A., Ayllon, J., Elaidi, R., Schöffski, P., Barrascout, E., Morel, A., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq554 · Cited by 153
Martín, M., Bell, R. H., Bourgeois, H. P., Brufsky, A., Diel, I., Eniu, A. E., Fallowfield, L. J., Fujiwara, Y., Jassem, J., Paterson, A. H. G., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3310 · Cited by 149
Decroisette, C., Monnet, I., Berard, H., Quéré, G., Caer, H. L., Bota, S., Audigier-Valette, C., Geriniere, L., Vernejoux, J.-M., & CHOUAID, C. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318206a1e3 · Cited by 143
Bisphosphonates in multiple myeloma
Djulbegović, B., Wheatley, K., Ross, H. F., Clark, O. A. C., Bos, G. M. J., Goldschmidt, H., Cremer, F. W., Alsina, M., & Glasmacher, A. G. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003188 · Cited by 141
Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review
Migliorati, C. A., Epstein, J. B., Abt, E., & Berenson, J. R. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.195 · Cited by 138
Barrett-Lee, P. J., Casbard, A. C., Abraham, J., Hood, K., Coleman, R. E., Simmonds, P., Timmins, H., Wheatley, D. A., Grieve, R., Griffiths, G. O., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70539-4 · Cited by 128
Self-citationGimsing, P., Carlson, K. E., Turesson, I., Fayers, P. M., Waage, A., Vangsted, A. J., Mylin, A. K., Gluud, C. N., Juliusson, G., Gregersen, H., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70198-4 · Cited by 117
Hadji, P., Claus, V., Ziller, V., Intorcia, M., Kostev, K., & Steinle, T. (2011) · Osteoporosis International · doi:10.1007/s00198-011-1535-z · Cited by 114
Self-citationBody, J. J., Bergmann, P., Boonen, S., Boutsen, Y., Devogelaer, J.-P., Goemaere, S., Reginster, J., Rozenberg, S., & Kaufman, J. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0439-4 · Cited by 113
Self-citationConsensus on the utility of bone markers in the malignant bone disease setting
Coleman, R. E., Costa, L., Fred Saad, C., Cook, R. J., Hadji, P., Terpos, E., Garnero, P., Brown, J. E., Body, J., Smith, M. R., et al. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.02.005 · Cited by 109
Self-citationDenosumab in patients with cancer—a surgical strike against the osteoclast
Brown, J. E., & Coleman, R. E. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.197 · Cited by 105
Self-citationWaltman, N. L., Twiss, J. J., Ott, C. C., Gross, G. J., Lindsey, A. M., Moore, T. E., Berg, K. E., & Kupzyk, K. A. (2009) · Osteoporosis International · doi:10.1007/s00198-009-1083-y · Cited by 103
Cancer treatment-induced bone loss in premenopausal women: A need for therapeutic intervention?
Hadji, P., Gnant, M., Body, J. J., Bundred, N. J., Brufsky, A., Coleman, R., Guise, T. A., Lipton, A., & Aapro, M. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.02.008 · Cited by 103
Self-citationManagement of cancer treatment-induced bone loss
Coleman, R. E., Rathbone, E. J., & Brown, J. E. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.36 · Cited by 102
Self-citationPopulation Pharmacokinetic Analysis of Denosumab in Patients with Bone Metastases from Solid Tumours
Gibiansky, L. V., Sutjandra, L., Doshi, S., Zheng, J., Sohn, W. Y., Peterson, M. C., Jang, G. R., Chow, A. T., & Ruixo, J. J. P. (2012) · Clinical Pharmacokinetics · doi:10.2165/11598090-000000000-00000 · Cited by 101
Clinical use of markers of bone turnover in metastatic bone disease
Seibel, M. J. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0320 · Cited by 93
Neto, A. S., Tobias‐Machado, M., Esteves, M. A., Senra, M. D., Wroclawski, M. L., Fonseca, F. L. A., dos Reis, R. B., Pompeo, A. C. L., & del Giglio, A. (2011) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2011.4 · Cited by 79
The metastatic microenvironment of breast cancer: Clinical implications
Coleman, R. E., Gregory, W. M., Marshall, H. C., Wilson, C., & Holen, I. (2013) · The Breast · doi:10.1016/j.breast.2013.07.010 · Cited by 76
Self-citationAndriole, G. L. (2012) · Yearbook of Urology · doi:10.1016/j.yuro.2012.06.017 · Cited by 72
Morrissey, C. M., Roudier, M. P., Dowell, A., True, L. D., Ketchanji, M., Welty, C. J., Corey, E., Lange, P. H., Higano, C. S., & Vessella, R. L. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1749 · Cited by 61
Lee, C. E., Leslie, W. D., Czaykowski, P., Gingerich, J., Geirnaert, M., & Lau, Y.-K. (2011) · Current Oncology · doi:10.3747/co.v18i4.746 · Cited by 35
Rhee, Y., Song, K., Park, S., Park, H. S., Lim, S.-K., & Park, B. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0283 · Cited by 28
The Role of Denosumab for Prevention of Skeletal-Related Complications in Multiple Myeloma
Hageman, K., Patel, K. C., Mace, K., & Cooper, M. R. (2013) · Annals of Pharmacotherapy · doi:10.1345/aph.1r776 · Cited by 28
Hadji, P., Aapro, M., Costa, L., & Gnant, M. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.03.002 · Cited by 19
Self-citationShapiro, C. L. (2013) · Breast Diseases A Year Book Quarterly · doi:10.1016/j.breastdis.2013.07.037 · Cited by 14
Heinemann, V., Reinacher‐Schick, A., Stintzing, S., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.30.4_suppl.511 · Cited by 12
Cited by
Harbeck, N., & Gnant, M. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31891-8 · Cited by 2,280
Macedo, F., Ladeira, K., Pinho, F., Saraiva, N., Bonito, N., Pinto, L., & Gonçalves, F. (2017) · Oncology Reviews · doi:10.4081/oncol.2017.321 · Cited by 775
Gillessen, S., Attard, G., Beer, T. M., Beltran, H., Bossi, A., Bristow, R., Carver, B., Castellano, D., Chung, B. H., Clarke, N., et al. (2018) · European Urology · doi:10.1016/j.eururo.2017.06.002 · Cited by 642
Coleman, R. E., Croucher, P. I., Padhani, A. R., Clézardin, P., Chow, E., Fallon, M., Guise, T., Colangeli, S., Capanna, R., & Costa, L. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00216-3 · Cited by 570
Self-citationThe Advisory Board of the National Osteoporosis Guideline Group, Kanis, J. A., Harvey, N. C., Cooper, C., Johansson, H., Odén, A., & McCloskey, E. V. (2016) · Archives of Osteoporosis · doi:10.1007/s11657-016-0278-z · Cited by 421
Metadata
- Authors
- Coleman, R., Body, J. J., Aapro, M., Hadji, P., & Herrstedt, J.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2014-09
- Volume
- 25
- Pages
- iii124-iii137
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2137458001
- Cited by
- 564
- References
- 98
- FWCI
- 21.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.